Welcome to ECBAY
Hot pharmaceutical raw material Ciprofloxacin Hcl BP/USP
Hot pharmaceutical raw material Ciprofloxacin Hcl BP/USP

1.Ciprofloxacin Hcl 2.Cas No.:86483-48-9 3.Pharmaceuticals 4.Compacted and micronised 5.USP34/USP32.

Hot pharmaceutical raw material Ciprofloxacin Hcl

1.CAS No:86393-32-0 2.GMP and COS certificated 3.prompt shipment 4.Professional exporter 5.High quality and good price

Ciprofloxacin Hydrochloride
[Chemical Name]
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid·Hydrochloride·Monohydrate
[Structure Formula]
 
[Molecular Formula]
C17H18FN3O3·HCl·H2O
[Molecular Weight]
385.81
[Specification]
USP32, EP6, BP2010
[Uses]
It is a broad-spectrum antibiotic of high efficacy

 

 

ANALYSIS AS PER USP 34 

Items of Test

Standard

Result of Test

Appearance

White or light yellow crystalline powder

conform

Identification

(a)   IR

(b)   TLC

 

 

(c) the reaction of chloride

 

IR spectrum of sample corresponds to that of reference standard.

The intensity and RF value of the principal band obtained from the test solution corresponds to that obtained from the standard solution.

A solution of IIresponds to the tests of chloride

 

Conform

 

Conform

 

 

Conform

Related substances HPLC

Chromatographic purity ≤ 0.2%

Ciprofloxacin ethylenediamine analog ≤ 0.2%

Unspecified impurity ≤ 0.50%

Total impurities ≤ 0.5%

0.15%

<0.11%

0.40%

Ph

3.0-4.5

3.7

Heavy metals

≤20ppm

<20ppm

Fluoroquinolonic acid

≤0.2%

Conform

Sulphated ash

≤0.04%

<0.04%

Water

4.7%-6.7%

5.90%

Residue of ignition

≤0.1%

0.05%

Residual solvent

ethanol ≤ 5000ppm

Isoamyl alcohol≤ 4000ppm

560ppm

Not found  

Assay (HPLC)

98.0%-102%

99.8%

Hot pharmaceutical raw material Ciprofloxacin Hcl BP/USP

Related Products
Ads by Google


About Us | Contact Us | Help | Terms & Conditions
Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
Copyright Notice @ 2008-2022 ECBAY Limited and/or its subsidiaries and licensors. All rights reserved.